A pilot study of three-cycle consolidation chemotherapy with paclitaxel and platinum in epithelial ovarian cancer patients with clinical complete response after paclitaxel and platinum chemotherapy
- 24 January 2006
- journal article
- clinical trial
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 16 (1) , 95-100
- https://doi.org/10.1111/j.1525-1438.2006.00282.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized StudyJournal of Clinical Oncology, 2004
- Phase III Randomized Trial of 12 Versus 3 Months of Maintenance Paclitaxel in Patients With Advanced Ovarian Cancer After Complete Response to Platinum and Paclitaxel-Based Chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group TrialJournal of Clinical Oncology, 2003
- Tamoxifen Therapy for Ovarian Cancer in the Adjuvant and Advanced Settings: Systematic Review of the Literature and Implications for Future ResearchGynecologic Oncology, 2002
- Whole Abdominal Radiotherapy Following Second-Look Laparotomy for Ovarian CarcinomaGynecologic Oncology, 1999
- A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinomaAnnals of Oncology, 1997
- A Prospective Randomized Comparison of 6 and 12 Cycles of Cyclophosphamide, Adriamycin, and Cisplatin in Advanced Epithelial Ovarian Cancer: A Danish Ovarian Study Group Trial (DACOVA)Gynecologic Oncology, 1993
- The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: “Maintenance” therapy reconsideredGynecologic Oncology, 1992
- Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinomaGynecologic Oncology, 1992
- Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapyGynecologic Oncology, 1991
- The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assayEuropean Journal of Cancer and Clinical Oncology, 1988